8-KFiled Sep 17, 8:00 PM ET

Melar Acquisition Corp. I Announces Merger with Everli

$MACI · Melar Acquisition Corp. I/Cayman

Research Summary

AI-generated summary of this SEC filing

Updated

Melar Acquisition Corp. I Announces Merger with Everli

What Happened

  • Melar Acquisition Corp. I (Melar) disclosed in an 8-K (filed Sept. 18, 2026) that on July 30, 2025 it entered into an Agreement and Plan of Merger with MAC I Merger Sub Inc. (a Melar subsidiary), Everli Global Inc., Melar Acquisition Sponsor I LLC (as shareholders’ representative) and Escrowed Seller Salvatore Palella.
  • Under the agreement, Melar will first de-register in the Cayman Islands and domesticate as a Nevada corporation, then Merger Sub will merge with and into Everli, with Everli surviving as a wholly owned subsidiary of Melar. An investor presentation related to the transaction was furnished as Exhibit 99.1.

Key Details

  • Agreement date: July 30, 2025; 8-K filing date: Sept. 18, 2026.
  • Transaction steps: domestication from Cayman Islands to Nevada, then merger of Merger Sub into Everli.
  • Post-closing structure: Everli will continue as the surviving entity and become a wholly owned subsidiary of Melar.
  • Parties named: Merger Sub (MAC I Merger Sub Inc.), Everli Global Inc., Melar Acquisition Sponsor I LLC (representative), and Escrowed Seller Salvatore Palella.

Why It Matters

  • This filing announces a definitive business combination that would convert Everli into a unit of the publicly listed Melar entity and changes Melar’s legal domicile from the Cayman Islands to Nevada.
  • For investors, the stepwise domestication and merger are material corporate events affecting ownership structure and may lead to Everli’s operations being consolidated in the public company once the transaction closes.
  • The agreement is subject to the terms and closing conditions in the merger agreement; shareholders should watch for further filings (e.g., proxy statements, closing notices) for timing, approvals, and additional financial details.